does semaglutide cause muscle weakness (GLP-1) Loss: Body Composition Changes and Findings From weight loss to muscle

Semaglutide mimics GLP-1 (glucose-like-peptide-1), whereas tirzepatide imitates both GLP-1 and another hormoneGIP (glucose-dependent insulinotropic polypeptide)

Cardiovascular Diabetology, 20 (1), 225

Treatment is typically provided for up to 2 years within the NHS, and ongoing prescribing is contingent on demonstrating a clinically meaningful weight loss response usually assessed after reaching the maintenance dose or at around 6 months of treatment

We require a comprehensive medical intake

Staying informed is one of the most useful things you can do throughout treatment

The FDA has issued warnings about counterfeit semaglutide products entering the supply chain, particularly through online pharmacies and unauthorized distributors